Oncodesign Services and Nexus BioQuest have formed a preclinical research [...]

A Pusan National University study has identified a signalling pathway [...]

Kupando has dosed the first patient in a Phase 1 [...]

Evogene has reported positive Phase 1 data for microbiome-based therapy [...]

Kainova Therapeutics has dosed the first European patient in its [...]

Kainova Therapeutics has dosed the first patient in Europe in [...]

ImmuneOncia Therapeutics and Lonza have entered into a manufacturing collaboration [...]

Kainova Therapeutics has secured $32m CAD in a Series B [...]

Kahimmune Therapeutics has signed an exclusive licensing agreement with Gustave [...]

Study shows tumour regression with no treatment-related toxicity in head [...]